Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older who have been diagnosed with a blood cancer (such as multiple myeloma or non-Hodgkin lymphoma) and are currently being treated with a type of medication called bispecific antibodies.
- People who started this bispecific antibody treatment no more than 30 days before joining the study.
- People who are able to understand and agree to participate in the study by giving informed consent.
- Serious infections will be tracked during the first year of the study, but infections that happen after the cancer comes back or after a new treatment is started will not be included in the study records.
Who may not be able to join:
- No specific exclusion criteria were listed in the official information provided (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0034 608008118
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of infections under biespecific treatment
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.